• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSpago Nanomedical AB (publ)
    Picture of Spago Nanomedical AB (publ) logo

    SPAGO — Spago Nanomedical AB (publ) Share News

    SEK0.110.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      SEK88.14m
    • Enterprise Value
      SEK62.21m
    • Revenue
      SEK0.44m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SPAGO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SPAGO Dividends
    • Brief: Spago Nanomedical To Be Granted US Patent For Tumorad

      05/03/2018 14:59
    • Brief: Spago Nanomedical Issues Shares With Proceeds At About SEK 8.7 Million

      01/03/2018 07:06
    • Brief: Spago Nanomedical Q3 operating loss widens to SEK 1.9 mln

      08/11/2017 07:30
    • Brief: Spago Nanomedical rights issue oversubscribed

      24/10/2017 13:26
    • Brief: Spago: Promising results in toxicological pilot studies with SpagoPix

      17/02/2017 12:55
    • Brief: Spago: SpagoPix product patent approved in Japan

      25/01/2017 14:14
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.